THC use disorders seemed to be associated with an increased risk of spirometry-defined SAD and lower small airways spirometric value in this population-based cohort, highlighting the need for screening of THC in patients investigated for SAD.
THC use disorders seemed to be associated with an increased risk of spirometry-defined SAD and lower small airways spirometric value in this population-based cohort, highlighting the need for screening of THC in patients investigated for SAD.
This study sought to characterize the biosignatures of craving through the measurement of HRV using a combination of ECG monitoring and EMA in individuals in the first year of a current AUD recovery attempt.
These findings confirm previous results among non–treatment seekers with less severe AUD and suggest that continued development of semaglutide for AUD is warranted.
The harm reduction toolkit was recently updated by AAPP member Michelle Geier. Content focuses on defining harm reduction, harm reduction services for individuals and communities, and the identification of potential barriers to pharmacist engagement in harm reduction practices. AAPP members receive complimentary, continuous access to toolkits. Non-members can purchase for a fee for a period of 3 months.
No summary available
The 2026 AAPP Summit schedule is full of important topics. From ADHD to harm reduction to hormone therapy, attendees will review common clinical challenges, get the latest insights and research, and engage with faculty during live Q&A. Register today for the Oct. 1-2, 2026, virtual event!
No summary available
No summary available
No summary available
Earn 10 hours of ACPE and BCPP credit (if eligible) during the AAPP Summit, Oct. 1-2, 2026! Topics range from Integrating New Alzheimer’s Disease Treatments into Clinical Practice to Psychodermatology. Review the full schedule and register today for $160 (members).
AAPP members have developed tools and toolkits for the benefit of fellow psychiatric pharmacists and to further the knowledge of other pharmacists and health care professionals. You are encouraged to share these to educate others and highlight the value of psychiatric pharmacists. For practice-related resources, explore the Employer Resource Center.
AAPP Communities are where members can interact throughout the year to discuss issues, ask questions, and explore emerging trends. The new platform (2024) allows each member significant flexibility for how to engage with the AAPP Communities.
No summary available
This year, the AAPP Foundation celebrates 15 years of advancing research, innovation, and workforce growth and development in psychiatric pharmacy! Thanks to two groups of generous donors, every contribution through Dec. 31, 2026, can be matched dollar-for-dollar, up to $30,000 for a total impact of $60,000! Join us in building toward the next 15 years. Make your gift today and double your impact. #AAPPFoundation #PsychiatricPharmacy #MatchingGift #DoubleYourImpact #Philanthropy
Over 2000 participants have completed our Psychotropic LAI Training Program. Join the ranks and start today! This grant-funded activity is offered complimentary and participants gain access to numerous LAI resources along with 6 educational webinars.
Advancing Patient Care Award application window is now open. Let’s recognize excellence in increasing patient access to high quality mental health care.
No summary available
No summary available